🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,425 results for “Elan” Clear

  1. Everolimus

    Jazz Pharmaceuticals Ireland Limited

    Diffuse Intrinsic Pontine Glioma

    phase 3 small molecule active

    1 trial

  2. Exa-cel

    Vertex Pharmaceuticals (Ireland) Limited

    Sickle Cell Disease

    phase 3 mab terminated

    1 trial

  3. Exparel

    Pacira Ireland Limited

    Lower Extremity Surgery

    phase 3 small molecule completed

    1 trial

  4. Exparel

    Pacira Ireland Limited

    Chronic Shoulder Pain

    phase 3 small molecule active

    1 trial

  5. Exparel

    Pacira Ireland Limited

    Back Pain

    phase 3 small molecule active

    1 trial

  6. Exparel

    Pacira Ireland Limited

    Mammaplasty

    phase 3 small molecule completed

    1 trial

  7. Exparel

    Pacira Ireland Limited

    Postoperative Pain Management

    phase 3 small molecule completed

    3 trials

  8. Exparel Injectable Product

    Pacira Ireland Limited

    Coronary Artery Disease

    phase 3 small molecule completed

    1 trial

  9. FILGRASTIM, CYCLOPHOSPHAMIDE, DOXORUBICIN, DEXRAZOXANE HYDROCHLORIDE

    Cancer Prevention Pharma (Ireland) Limited

    Advanced or metastatic soft tissue sarcoma (STS) in patients ≥65 years old

    phase 3 small molecule active

    1 trial

  10. FLUOROURACIL, DOCETAXEL, OPDIVO 10 mg/mL concentrate for solution for infusion., OXALIPLATIN, CALCIUM LEVOFOLINATE, CISPLATIN, DOXORUBICIN HYDROCHLORIDE

    Verona Pharma Ireland Limited

    Gastric adenocarcinoma with peritoneal metastases

    phase 3 small molecule active

    1 trial

  11. FUROSEMIDE , DULOXETINE

    Cancer Prevention Pharma (Ireland) Limited

    ER positive HER2 negative breast cancer stages I-II

    phase 3 small molecule active

    1 trial

  12. FX006

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    2 trials

  13. FX006

    Pacira Ireland Limited

    Osteoarthritis, Hip

    phase 3 small molecule terminated

    1 trial

  14. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    1 trial

  15. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    4 trials

  16. Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes

    Lxo Ireland Designated Activity Company

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  17. Femara 2.5 mg film-coated tablets, Cisplatin 1 mg/ml Concentrate for Solution for Infusion, Anastrozole 1mg film-coated tablets, Docetaxel Pfizer 10 mg/mL concentrate for solution for infusion, Paclitaxel 6 mg/ml Concentrate for Solution for Infusion, Exemestane 25 mg Film-coated Tablets, Carboplatin 10 mg/ml Concentrate for Solution for Infusion, Abraxane 5 mg/ml powder for dispersion for infusion.

    Cancer Prevention Pharma (Ireland) Limited

    low-grade serous carcinoma of the ovary or peritoneum

    phase 3 small molecule active

    1 trial

  18. Fianlimab

    Regeneron UK Limited

    Melanoma

    phase 3 small molecule active

    3 trials

  19. Fordadistrogene Movaparvovec, ECULIZUMAB, Placebo for PF-06939926

    Pfizer Ireland Pharmaceuticals Unlimited Company

    DUCHENNE MUSCULAR DYSTROPHY (DMD)

    phase 3 small molecule active

    1 trial

  20. GW-1000-02

    Jazz Pharmaceuticals Ireland Limited

    Multiple Sclerosis

    phase 3 small molecule completed

    4 trials

  21. GW-1000-02

    Jazz Pharmaceuticals Ireland Limited

    Pain

    phase 3 small molecule completed

    3 trials

  22. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Epilepsy

    phase 3 small molecule completed

    5 trials

  23. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Rett Syndrome

    phase 3 small molecule terminated

    2 trials

  24. GWP42003-P

    Jazz Pharmaceuticals Ireland Limited

    Tuberous Sclerosis Complex

    phase 3 small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources